[{"AccountsPayableCurrent_0_Q1_USD":3779000.0,"ContractWithCustomerAssetNet_0_Q1_USD":2351000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-11882000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":849000.0,"EquityMethodInvestments_0_Q1_USD":100000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1635000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":849000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-1668000.0,"Dividends_1_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":59578000.0,"OtherAssetsCurrent_0_Q1_USD":593000.0,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":-163000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":118000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q1_USD":4000000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q1_USD":6000000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q1_USD":5500000.0,"DeferredRevenueCurrent_0_Q1_USD":8096000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-9777000.0,"ContractWithCustomerLiability_0_Q1_USD":21911000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":-2646000.0,"DeferredRevenueNoncurrent_0_Q1_USD":13815000.0,"InterestExpenseLongTermDebt_1_Q1_USD":300000.0,"RestrictedCashNoncurrent_0_Q1_USD":107000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-274000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.084,"OperatingLeaseRightOfUseAsset_0_Q1_USD":5567000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":4629000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1474000.0,"OperatingLeaseLiability_0_Q1_USD":6103000.0,"OperatingLeaseCost_1_Q1_USD":400000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":1746000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":1298000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1489000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":1427000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":1349000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":1390000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":1432000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":314000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":7401000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q1_USD":0.0,"LongTermDebtNoncurrent_0_Q1_USD":15028000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":262000.0,"PrepaidExpenseCurrent_0_Q1_USD":1344000.0,"LiabilitiesCurrent_0_Q1_USD":21650000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":72104000.0,"Liabilities_0_Q1_USD":55122000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1179000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":172000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-2276000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"GeneralAndAdministrativeExpense_1_Q1_USD":4191000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":118000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.67,"CommonStockSharesOutstanding_0_Q1_shares":15157000.0,"CommonStockSharesIssued_0_Q1_shares":15157000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":59471000.0,"AssetsCurrent_0_Q1_USD":63759000.0,"Assets_0_Q1_USD":72104000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":316957.0,"AdditionalPaidInCapital_0_Q1_USD":98412000.0,"AccountsReceivableNetCurrent_0_Q1_USD":2351000.0,"CommonStockValue_0_Q1_USD":15000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":2646000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-142000.0,"NetIncomeLoss_1_Q1_USD":-9777000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-152000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":4934000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":2363000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":118000.0,"ShareBasedCompensation_1_Q1_USD":849000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":7917000.0,"OperatingIncomeLoss_1_Q1_USD":-9462000.0,"OperatingExpenses_1_Q1_USD":12108000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-11858000.0,"InterestPaidNet_1_Q1_USD":228000.0,"CommonStockSharesAuthorized_0_Q1_shares":30000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"AccruedLiabilitiesCurrent_0_Q1_USD":9775000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":14521000.0,"StockholdersEquity_0_Q1_USD":16982000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-81445000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2571000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":142000.0,"DepreciationAndAmortization_1_Q1_USD":182000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":674000.0,"Ticker":"ARCT","CIK":"1768224","name":"ARCTURUS THERAPEUTICS HOLDINGS INC.","OfficialName":"Arcturus Therapeutics Holdings Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"666232551.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200508"}]